Cellnovo Group announced the achievement of CE marking of its next-generation mobile diabetes management system, making it the first insulin delivery platform to use Bluetooth® Low Energy and Android™. The use of a wireless communication technology and a standard mobile operating system will further enable interoperability with other e-health platforms, including artificial pancreas projects. This adds to the Cellnovo System’s unique value proposition as the first and only e-connected micro-pump, which provides real time data to patients and clinicians. The Company’s next-generation system, the Cellnovo System with Android, builds upon the current system in three main aspects: The adoption of standard technologies will facilitate the interoperability of the Cellnovo System with other connected objects for health and well-being. The next-generation system will thus be capable of communicating with devices such as continuous glucose meters, blood glucose meters, fitness trackers, and smart watches, providing a holistic vision of the patient’s health. These innovations provide Cellnovo with a best-in-class platform to be used for the Company’s future artificial pancreas and automated insulin delivery (AID) product lines. The Cellnovo micro-pump will communicate wirelessly with the touchscreen handset using Bluetooth® Low Energy, a standard communication technology dedicated to connected objects. This technology guarantees the quality of communications while significantly reducing energy consumption. The use of the Android™ operating system improves the performance of Cellnovo's proprietary touchscreen handset.